Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
telomerase inhibitor |
| gptkbp:administeredBy |
intravenous injection
|
| gptkbp:alternativeName |
imetelstat
|
| gptkbp:CASNumber |
868540-17-4
|
| gptkbp:clinicalTrialPhase |
Phase II
|
| gptkbp:developedBy |
Geron Corporation
|
| https://www.w3.org/2000/01/rdf-schema#label |
GRN163L
|
| gptkbp:investigatedBy |
gptkb:acute_myeloid_leukemia
gptkb:myelofibrosis myelodysplastic syndromes |
| gptkbp:macromoleculeType |
oligonucleotide
|
| gptkbp:mechanismOfAction |
inhibits telomerase activity
|
| gptkbp:status |
investigational drug
|
| gptkbp:target |
telomerase RNA template
|
| gptkbp:usedFor |
gptkb:cancer
|
| gptkbp:bfsParent |
gptkb:telomerase_complex
|
| gptkbp:bfsLayer |
7
|